BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 11337062)

  • 21. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H; Koziolová E; Chytil P; Tsukigawa K; Fang J; Haratake M; Ulbrich K; Etrych T; Maeda H
    Mol Pharm; 2016 Dec; 13(12):4106-4115. PubMed ID: 27934482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The comparison of in vivo properties of water-soluble HPMA-based polymer conjugates with doxorubicin prepared by controlled RAFT or free radical polymerization.
    Chytil P; Šírová M; Koziolová E; Ulbrich K; Říhová B; Etrych T
    Physiol Res; 2015; 64(Suppl 1):S41-9. PubMed ID: 26447594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric drug-carriers containing doxorubicin and melanocyte-stimulating hormone: in vitro and in vivo evaluation against murine melanoma.
    O'Hare KB; Duncan R; Strohalm J; Ulbrich K; Kopeckova P
    J Drug Target; 1993; 1(3):217-29. PubMed ID: 8069563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin bound to a HPMA copolymer carrier through hydrazone bond is effective also in a cancer cell line with a limited content of lysosomes.
    Ríhová B; Etrych T; Pechar M; Jelínková M; Stastný M; Hovorka O; Kovár M; Ulbrich K
    J Control Release; 2001 Jul; 74(1-3):225-32. PubMed ID: 11489498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPMA copolymer-bound doxorubicin induces immunogenic tumor cell death.
    Sirova M; Kabesova M; Kovar L; Etrych T; Strohalm J; Ulbrich K; Rihova B
    Curr Med Chem; 2013; 20(38):4815-26. PubMed ID: 24083609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
    Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment.
    Noack AK; Lucas H; Chytil P; Etrych T; Mäder K; Mueller T
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators.
    Ríhová B; Jelínková M; Strohalm J; Subr V; Plocová D; Hovorka O; Novák M; Plundrová D; Germano Y; Ulbrich K
    J Control Release; 2000 Feb; 64(1-3):241-61. PubMed ID: 10640661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin release is not a prerequisite for the in vitro cytotoxicity of HPMA-based pharmaceuticals: in vitro effect of extra drug-free GlyPheLeuGly sequences.
    Ríhová B; Strohalm J; Hovorka O; Subr V; Etrych T; Chytil P; Pola R; Plocová D; Boucek J; Ulbrich K
    J Control Release; 2008 Apr; 127(2):110-20. PubMed ID: 18325618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(ethylene glycol)-poly(ester-carbonate) block copolymers carrying PEG-peptidyl-doxorubicin pendant side chains: synthesis and evaluation as anticancer conjugates.
    Andersson L; Davies J; Duncan R; Ferruti P; Ford J; Kneller S; Mendichi R; Pasut G; Schiavon O; Summerford C; Tirk A; Veronese FM; Vincenzi V; Wu G
    Biomacromolecules; 2005; 6(2):914-26. PubMed ID: 15762660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New HPMA copolymer-based drug carriers with covalently bound hydrophobic substituents for solid tumour targeting.
    Chytil P; Etrych T; Konák C; Sírová M; Mrkvan T; Boucek J; Ríhová B; Ulbrich K
    J Control Release; 2008 Apr; 127(2):121-30. PubMed ID: 18304673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Starlike vs. classic macromolecular prodrugs: two different antibody-targeted HPMA copolymers of doxorubicin studied in vitro and in vivo as potential anticancer drugs.
    Jelínková M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Pharm Res; 2003 Oct; 20(10):1558-64. PubMed ID: 14620507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-association properties of HPMA copolymers containing an amphipathic heptapeptide.
    Ding H; Kopecková P; Kopecek J
    J Drug Target; 2007; 15(7-8):465-74. PubMed ID: 17671893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HPMA copolymer-doxorubicin conjugates: The effects of molecular weight and architecture on biodistribution and in vivo activity.
    Etrych T; Subr V; Strohalm J; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2012 Dec; 164(3):346-54. PubMed ID: 22759979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer-beta-lactamase and HPMA copolymer-C-Dox as a model combination.
    Satchi-Fainaro R; Hailu H; Davies JW; Summerford C; Duncan R
    Bioconjug Chem; 2003; 14(4):797-804. PubMed ID: 12862433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic action of doxorubicin bound to the polymeric carrier based on N-(2-hydroxypropyl)methacrylamide copolymers through an amide or hydrazone bond.
    Ríhová B; Etrych T; Sírová M; Kovár L; Hovorka O; Kovár M; Benda A; Ulbrich K
    Mol Pharm; 2010 Aug; 7(4):1027-40. PubMed ID: 20524698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of starlike N-(2-hydroxypropyl)methacrylamide copolymers: potential drug carriers.
    Wang D; Kopecková JP; Minko T; Nanayakkara V; Kopecek J
    Biomacromolecules; 2000; 1(3):313-9. PubMed ID: 11710118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.